Virginia Retirement Systems’s Royalty Pharma RPRX Stock Holding History

Virginia Retirement Systems’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-221,649	Closed	-$7.99M	–	1089
2023 Q1	$7.99M	Sell	221,649 -215,151	-49%	-$7.98M	0.08%	214
2022 Q4	$17.3M	Buy	436,800 +96,200	+28%	+$4.02M	0.18%	144
2022 Q3	$13.7M	Buy	+340,600	New	+$14.5M	0.15%	159
2022 Q1	$4.82M	Buy	123,800 +5,500	+5%	+$216K	0.05%	305
2021 Q4	$4.71M	Hold	118,300	–	–	0.03%	310
2021 Q3	$4.28M	Buy	118,300 +100,000	+546%	+$3.89M	0.04%	291
2021 Q2	$750K	Buy	+18,300	New	+$778K	0.01%	739

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's RPRX Position: Q2 2023 in Review

Virginia Retirement Systems sold out of Royalty Pharma (RPRX) in Q2 2023, closing a stake of 221,649 shares — an estimated $7.99M sold.

Virginia Retirement Systems first reported a position in RPRX in Q2 2021 and held it in 7 quarters. The position peaked at $17.3M in Q4 2022. 325 funds tracked by Wall St. Rank hold RPRX as of Q2 2023.

Virginia Retirement Systems reported no remaining Royalty Pharma position as of Q2 2023 after selling out during the quarter.
Virginia Retirement Systems sold 221,649 Royalty Pharma shares in Q2 2023, an estimated $7.99M.
Virginia Retirement Systems first reported a position in Royalty Pharma in Q2 2021 and held it in 7 quarters.
Virginia Retirement Systems's Royalty Pharma position peaked at $17.3M in Q4 2022.
325 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.